New eye gel could ease rosacea symptoms
NCT ID NCT07443202
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 2 trial tests a gel called lotilaner for people with moderate to severe ocular rosacea, a condition causing red, irritated eyes. About 155 adults will receive either the gel or a placebo to see if it is safe and helps symptoms. The study is currently enrolling by invitation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- lotilaner ophthalmic gel
- What this could lead to
- If it works, this could point toward a new treatment option for ocular rosacea, reducing redness and discomfort.
- What could go wrong
- This is an early Phase 2 study with only 155 participants, so results may not confirm effectiveness. Safety and tolerability are the main focus, and the gel may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCULAR ROSACEA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Site
Houston, Texas, 77027, United States
-
Site
Lynchburg, Virginia, 24502, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.